What happened
Metabiomed filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$17.5M (+13.8% year on year), operating profit of US$1.72M (−46.7% year on year) and net income of US$32.6K (−99.5% year on year).
These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.
| Revenue | US$17.5M |
|---|---|
| Revenue vs a year earlier | +13.8% |
| Operating profit | US$1.72M |
| Net income | US$32.6K |
| Period | Q4 2025 (consolidated) |
| Filed | 2026-03-16, Operating results (consolidated) (preliminary) (fair disclosure) |
| Source | DART rcept 20260316900967 → open original filing |
Source: DART. Information only, not investment advice.